GlassScriptPhysician profile
Brian S Winters
NPI 1740456318
$69,997.44
in general payments reported to CMS, 2019-2025
14 companies · $20K in 2025
The $20K reported for 2025 was more than what 91% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,078 · 2020: $383 · 2021: $112 · 2022: $27K · 2023: $16K · 2024: $5,243 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Travel and Lodging: $5,942 · Food and Beverage: $2,049 · Royalty Or License: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,376.36 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,000.00 |
| Travel and Lodging | $5,941.54 |
| Food and Beverage | $2,049.21 |
| Royalty Or License | $145.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $60,725.54 | 2020-2025 | Cadence, Salto Talaris Total Ankle Prosthesis, Panta 2 |
| Restor3d, INC. | $6,402.92 | 2023-2025 | |
| Liberty Surgical INC. | $1,877.00 | 2019 | |
| Integra Lifesciences Corporation | $269.94 | 2019-2020 | |
| Wright Medical Technology, INC. | $231.49 | 2019-2020 | |
| Stryker Corporation | $188.29 | 2023-2025 | Gamma, Augment Injectable, T2 Alpha |
| Eclipse Technology Solutions INC. | $81.27 | 2024-2025 | |
| Bioventus LLC | $57.43 | 2022 | |
| Arthrex, INC. | $49.92 | 2025 | |
| Depuy Synthes Sales INC. | $48.75 | 2019-2021 | |
| Linvatec Corporation | $19.12 | 2023 | Biobrace 23mm |
| Pfizer INC. | $17.78 | 2019 | |
| Endo Pharmaceuticals INC. | $14.10 | 2021 | |
| Horizon Therapeutics Plc | $13.89 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,253.48 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Winters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.